Nello Mainolfi, CEO: Kymera Therapeutics KYMR Sell · Filed 25/10/29

Trade details

Type: Insider sale
Amount: $1,495,661.22
Shares · price: 24,511 sh · $61.02 a share
Held after: 664,109 sh
Stock: Kymera Therapeutics KYMR
Person: Nello MainolfiCEO
Trade date: 25/10/29
Filed: 25/10/29
Days to filing: 0 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/29~25/11/28

Nello Mainolfi's recent trades

Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$6M
50,000 sh
$6M
Filed 07/07
Traded 07/07
Nello MainolfiCEO
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$9.1M
80,000 sh
$9.1M
Filed 07/02
Traded 07/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$1.4M
17,005 sh
$1.4M
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$985.2K
12,059 sh
$985.2K
Filed 04/29
Traded 04/29
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$77.2K
936 sh
$77.2K
Filed 04/29
Traded 04/29

Nello Mainolfi, CEO — sold $1.5M of Kymera Therapeutics KYMR · 3.6% of holdings · 10b5-1 plan | Whalegun